• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSB2101003 PDR001注射用粉末 spartalizumab Other Biological Products(1) Supplementary Application 2021-04-14 Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JXSL2000094 PDR001注射用浓溶液 spartalizumab Injection Biological Products Import Drug Application 2020-07-03 诺华(中国)生物医学研究有限公司 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG In Review 2020-07-02 view
JXSL1900101 PDR001注射用浓溶液 spartalizumab Injection Biological Products Import Drug Application 2019-09-29 诺华(中国)生物医学研究有限公司 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG In Review 2019-09-28 view
JXSL1900102 PDR001注射用粉末 spartalizumab Other Biological Products Import Drug Application 2019-09-29 诺华(中国)生物医学研究有限公司 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG In Review 2019-09-28 view
JXSL1900021 PDR001注射用浓溶液 spartalizumab Injection Biological Products Import Drug Application 2019-02-25 诺华(中国)生物医学研究有限公司 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG In Review 2019-02-23 view
JXSL1700041 PDR001 spartalizumab Other Biological Products Import Drug Application 2017-08-16 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2017-12-20 view
JXSL1600032 PDR001 spartalizumab Other Biological Products Import Drug Application 2016-07-04 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG Certificate Issued 2017-05-18 view
JXSL1600016 PDR001 spartalizumab Other Biological Products Import Drug Application 2016-03-23 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG Certificate Issued 2017-05-26 view